BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and ...
Conestoga Capital Advisors, an asset management company, released its “Conestoga Micro Cap Growth Fund” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, ...
BioLife Solutions, an established biotech firm, is poised to benefit from the booming cell and gene therapy sector, projected to grow significantly by 2030. Despite recent negative EPS, BioLife has ...
HENDERSON, NV, Feb. 16, 2022 (GLOBE NEWSWIRE) -- viaNewMediaWire-- BioLife Sciences (OTC: Markets: BLFE)today announced the launch of their new antimicrobial copper-infused fabric pot. The BioLife ...
BioLife Solutions (BLFS-2.70%) is starting the week with a bang. On Monday morning, the company announced it has signed a definitive agreement to purchase privately held SciSafe. The price is $30 ...
BioLife is a cell- and gene-therapy bioproduction tools and services company. It makes cell-storage media, thawing solutions, cold chain accessories, and cryopreservation freeze media products. Its ...
The MarketWatch News Department was not involved in the creation of this content. Fourth quarter unaudited revenue from continuing operations of $24.8 million increased 20% from the prior year fourth ...
A blood plasma center that opened in Moorhead in April is drawing more donors than anticipated. When BioLife Plasma Services opened at 2960 12th St. S., it took in 250 donors a week. Now the center ...
In the preceding three months, 4 analysts have released ratings for BioLife Solns (NASDAQ:BLFS), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their ...
BioLife Plasma Services abruptly closed two of its three Wyoming locations Tuesday. Clients, who said they depend on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results